Exploring the impact of CR disruption in PD opens new avenues for therapeutic interventions ranging from pharmacological to non-pharmacological applications to restore circadian dynamics or using the clock profiles as biomarkers for disease monitoring and management. The gene discussed is CLOCK; the disease is Parkinson disease.